Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q
Source: 0001731122-25-000258
Chunk: 7

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q
Item: Part I, Item 1
Chunk 7
---
631  
     —  
     —  
     558,631 
  
    Net loss 
     —  
     —  
     —  
     —  
     —  
     (7,252,394) 
     —  
     (7,252,394)
  
    Foreign currency translation adjustment 
     —  
     —  
     —  
     —  
     —  
     —  
     (10,144,818) 
     (10,144,818)

    December 31, 2024 
     —  
    $—  
     162,142,907  
    $16,216  
    $469,810,215  
    $(383,919,510) 
    $(3,847,603) 
    $82,059,318 

See accompanying notes to the unaudited condensed consolidated
financial statements.

6

RENOVARO INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(UNAUDITED)

    For the Six Months Ended

    December 31,

    2024 
    2023
  
    CASH FLOWS FROM OPERATING ACTIVITIES: 

    Net loss 
    $(51,464,429) 
    $(13,704,149)

    ADJUSTMENTS TO RECONCILE NET LOSS TO NET CASH USED IN OPERATING ACTIVITIES: 

    Depreciation and amortization 
     64,494  
     60,422 
  
    Loss on extinguishment of debt 
     —  
     120,018 
  
    Changed in value of contingent consideration 
     (6,660,000) 
     — 
  
    Stock-based compensation expense 
     916,279  
     1,983,057 
  
    Restricted shares for services rendered (including $137,000 of compensation expense) 
     1,930,901  
     4,470,000 
  
    Goodwill impairment 
     47,614,729  
     — 
  
    Amortization of discount of notes payable 
     32,024  
     364,415 
  
    Changes in assets and liabilities: 

    Other receivables